Highly active non-metals doped mixed-phase TiO2 for photocatalytic oxidation of ibuprofen under visible light

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • T.M. Khedr
  • S.M. El-Sheikh
  • A. Hakki
  • A.A. Ismail
  • W.A. Badawy
  • D.W. Bahnemann

Organisationseinheiten

Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)530-540
Seitenumfang11
FachzeitschriftJournal of Photochemistry and Photobiology A: Chemistry
Jahrgang346
Frühes Online-Datum4 Juli 2017
PublikationsstatusVeröffentlicht - 1 Sept. 2017

Abstract

Visible light-activated C, N, S-tri-doped mesoporous anatase-brookite heterojunction TiO 2 photocatalyst has been synthesized by a facile hydrothermal method. The XRD and Raman spectra data revealed the formation of mixed anatase and brookite phases. The FE-SEM and TEM images demonstrated the formation of brookite phase with a rod-like structure composed of much smaller particles of anatase phase. N 2 isotherm measurements exhibited that both doped and undoped TiO 2 have mesoporous structure and their surface area measurements were reduced from 62 to 30 cm 2 g −1after non-metals doping. The photocatalytic oxidation of the ibuprofen (IBF) has been evaluated using prepared photocatalysts under visible light. The photocatalytic activity of the mesoporous C, N and S co-doped TiO 2 photocatalyst dramatically increased, achieving complete IBF degradation with an initial 1st order rate 1.779 μM min −1 for 5 h. The photonic efficiency (ξ) of IBF degradation under visible light with ABH (un-doped) and DABH (doped) photocatalysts are 0.044% and 1.84%, respectively. The reaction rate of doped photocatalyst is greater 40 times than non-doped one. The results demonstrated the advantages of the synthetic approach and the great potential of the driven visible light C, N and S co-doped TiO 2 photocatalysts for the treatment of residual pharmaceuticals in contaminated water under visible light.

Zitieren

Highly active non-metals doped mixed-phase TiO2 for photocatalytic oxidation of ibuprofen under visible light. / Khedr, T.M.; El-Sheikh, S.M.; Hakki, A. et al.
in: Journal of Photochemistry and Photobiology A: Chemistry, Jahrgang 346, 01.09.2017, S. 530-540.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Khedr TM, El-Sheikh SM, Hakki A, Ismail AA, Badawy WA, Bahnemann DW. Highly active non-metals doped mixed-phase TiO2 for photocatalytic oxidation of ibuprofen under visible light. Journal of Photochemistry and Photobiology A: Chemistry. 2017 Sep 1;346:530-540. Epub 2017 Jul 4. doi: 10.1016/j.jphotochem.2017.07.004
Download
@article{4da7012592354175b784c0cb726ef1e1,
title = "Highly active non-metals doped mixed-phase TiO2 for photocatalytic oxidation of ibuprofen under visible light",
abstract = "Visible light-activated C, N, S-tri-doped mesoporous anatase-brookite heterojunction TiO 2 photocatalyst has been synthesized by a facile hydrothermal method. The XRD and Raman spectra data revealed the formation of mixed anatase and brookite phases. The FE-SEM and TEM images demonstrated the formation of brookite phase with a rod-like structure composed of much smaller particles of anatase phase. N 2 isotherm measurements exhibited that both doped and undoped TiO 2 have mesoporous structure and their surface area measurements were reduced from 62 to 30 cm 2 g −1after non-metals doping. The photocatalytic oxidation of the ibuprofen (IBF) has been evaluated using prepared photocatalysts under visible light. The photocatalytic activity of the mesoporous C, N and S co-doped TiO 2 photocatalyst dramatically increased, achieving complete IBF degradation with an initial 1st order rate 1.779 μM min −1 for 5 h. The photonic efficiency (ξ) of IBF degradation under visible light with ABH (un-doped) and DABH (doped) photocatalysts are 0.044% and 1.84%, respectively. The reaction rate of doped photocatalyst is greater 40 times than non-doped one. The results demonstrated the advantages of the synthetic approach and the great potential of the driven visible light C, N and S co-doped TiO 2 photocatalysts for the treatment of residual pharmaceuticals in contaminated water under visible light. ",
keywords = "Anatase/brookite TiO, Ibuprofen, Non-metal doping, Photodegradation, Visible light",
author = "T.M. Khedr and S.M. El-Sheikh and A. Hakki and A.A. Ismail and W.A. Badawy and D.W. Bahnemann",
note = "Publisher Copyright: {\textcopyright} 2017 Elsevier B.V. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2017",
month = sep,
day = "1",
doi = "10.1016/j.jphotochem.2017.07.004",
language = "English",
volume = "346",
pages = "530--540",
journal = "Journal of Photochemistry and Photobiology A: Chemistry",
issn = "1010-6030",
publisher = "Elsevier",

}

Download

TY - JOUR

T1 - Highly active non-metals doped mixed-phase TiO2 for photocatalytic oxidation of ibuprofen under visible light

AU - Khedr, T.M.

AU - El-Sheikh, S.M.

AU - Hakki, A.

AU - Ismail, A.A.

AU - Badawy, W.A.

AU - Bahnemann, D.W.

N1 - Publisher Copyright: © 2017 Elsevier B.V. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Visible light-activated C, N, S-tri-doped mesoporous anatase-brookite heterojunction TiO 2 photocatalyst has been synthesized by a facile hydrothermal method. The XRD and Raman spectra data revealed the formation of mixed anatase and brookite phases. The FE-SEM and TEM images demonstrated the formation of brookite phase with a rod-like structure composed of much smaller particles of anatase phase. N 2 isotherm measurements exhibited that both doped and undoped TiO 2 have mesoporous structure and their surface area measurements were reduced from 62 to 30 cm 2 g −1after non-metals doping. The photocatalytic oxidation of the ibuprofen (IBF) has been evaluated using prepared photocatalysts under visible light. The photocatalytic activity of the mesoporous C, N and S co-doped TiO 2 photocatalyst dramatically increased, achieving complete IBF degradation with an initial 1st order rate 1.779 μM min −1 for 5 h. The photonic efficiency (ξ) of IBF degradation under visible light with ABH (un-doped) and DABH (doped) photocatalysts are 0.044% and 1.84%, respectively. The reaction rate of doped photocatalyst is greater 40 times than non-doped one. The results demonstrated the advantages of the synthetic approach and the great potential of the driven visible light C, N and S co-doped TiO 2 photocatalysts for the treatment of residual pharmaceuticals in contaminated water under visible light.

AB - Visible light-activated C, N, S-tri-doped mesoporous anatase-brookite heterojunction TiO 2 photocatalyst has been synthesized by a facile hydrothermal method. The XRD and Raman spectra data revealed the formation of mixed anatase and brookite phases. The FE-SEM and TEM images demonstrated the formation of brookite phase with a rod-like structure composed of much smaller particles of anatase phase. N 2 isotherm measurements exhibited that both doped and undoped TiO 2 have mesoporous structure and their surface area measurements were reduced from 62 to 30 cm 2 g −1after non-metals doping. The photocatalytic oxidation of the ibuprofen (IBF) has been evaluated using prepared photocatalysts under visible light. The photocatalytic activity of the mesoporous C, N and S co-doped TiO 2 photocatalyst dramatically increased, achieving complete IBF degradation with an initial 1st order rate 1.779 μM min −1 for 5 h. The photonic efficiency (ξ) of IBF degradation under visible light with ABH (un-doped) and DABH (doped) photocatalysts are 0.044% and 1.84%, respectively. The reaction rate of doped photocatalyst is greater 40 times than non-doped one. The results demonstrated the advantages of the synthetic approach and the great potential of the driven visible light C, N and S co-doped TiO 2 photocatalysts for the treatment of residual pharmaceuticals in contaminated water under visible light.

KW - Anatase/brookite TiO

KW - Ibuprofen

KW - Non-metal doping

KW - Photodegradation

KW - Visible light

UR - http://www.scopus.com/inward/record.url?scp=85021861865&partnerID=8YFLogxK

U2 - 10.1016/j.jphotochem.2017.07.004

DO - 10.1016/j.jphotochem.2017.07.004

M3 - Article

VL - 346

SP - 530

EP - 540

JO - Journal of Photochemistry and Photobiology A: Chemistry

JF - Journal of Photochemistry and Photobiology A: Chemistry

SN - 1010-6030

ER -